Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota

Journal: Nature Medicine

Published: 2020-02-17

DOI: 10.1038/s41591-020-0764-0

Affiliations: 12

Authors: 20

Go to article
Institutions Share
Division of Gastroenterology and Hepatology, U-M, United States of America (USA) 0.35
Department of Medical Biochemistry and Cell Biology, GU, Sweden 0.15
Department of Microbiology and Immunology, U-M, United States of America (USA) 0.15
Institute for Advanced Biosciences (IAB), Keio University, Japan 0.12
Division of Infectious Diseases, U-M, United States of America (USA) 0.10
Department of Genomic Medicine, MD Anderson Cancer Center, United States of America (USA) 0.05
Division of Molecular Immunology, Chiba University, Japan 0.02
International Research and Development Center for Mucosal Vaccine, UTokyo, Japan 0.02
Precursory Research for Innovative Medical Care (PRIME), AMED, Japan 0.02
Kanagawa Institute of Industrial Science and Technology (KISTEC), Japan 0.02
Transborder Medical Research Center, University of Tsukuba, Japan 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER